As on Wednesday, Becton Dickinson & Co. (NYSE: BDX) got off with the flyer as it spiked 0.34% to $240.52, before settling in for the price of $239.71 at the close. Taking a more long-term approach, BDX posted a 52-week range of $218.75-$262.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 4.86%. Meanwhile, its Annual Earning per share during the time was 52.43%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.38%. This publicly-traded company’s shares outstanding now amounts to $290.39 million, simultaneously with a float of $288.63 million. The organization now has a market capitalization sitting at $69.52 billion.
Becton Dickinson & Co. (BDX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Instruments & Supplies industry. Becton Dickinson & Co.’s current insider ownership accounts for 0.14%, in contrast to 89.94% institutional ownership. Preceding that transaction, on Jun 10 ’24, Company’s SVP,Controller&Chief Acct Off sold 300 for 239.31, making the whole transaction’s value amount to 71,793. This particular insider is now the holder of 1,976 in total.
Becton Dickinson & Co. (BDX) Earnings and Revenue Records
Becton Dickinson & Co.’s EPS increase for this current 12-month fiscal period is 7.38% and is forecasted to reach 14.34 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.00% through the next 5 years, which can be compared against the 52.43% growth it accomplished over the previous five years trading on the market.
Becton Dickinson & Co. (NYSE: BDX) Trading Performance Indicators
Let’s observe the current performance indicators for Becton Dickinson & Co. (BDX). It’s Quick Ratio in the last reported quarter now stands at 1.36. The Stock has managed to achieve an average true range (ATR) of 3.57. Alongside those numbers, its PE Ratio stands at $49.48, and its Beta score is 0.43. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.51. Similarly, its price to free cash flow for trailing twelve months is now 21.58.
In the same vein, BDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 4.86, a figure that is expected to reach 3.77 in the next quarter, and analysts are predicting that it will be 14.34 at the market close of one year from today.
